Page last updated: 2024-10-22

alprenolol and Glaucoma

alprenolol has been researched along with Glaucoma in 1 studies

Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polgar, P1
Bodor, N1

Other Studies

1 other study available for alprenolol and Glaucoma

ArticleYear
Minimal cardiac electrophysiological activity of alprenoxime, a site-activated ocular beta-blocker, in dogs.
    Life sciences, 1995, Volume: 56, Issue:14

    Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Antihypertensive Agents; Biotransformation; Dogs;

1995